Enhanced phagocytosis associated with multinucleated microglia via Pyk2 inhibition in an acute β-amyloid infusion model-Reference-Cited by-同舟云学术

Enhanced phagocytosis associated with multinucleated microglia via Pyk2 inhibition in an acute β-amyloid infusion model

Published:2024-08-06 Issue:1 Volume:21 Page:
ISSN:1742-2094
Container-title:Journal of Neuroinflammation
language:en
Short-container-title:J Neuroinflammation

Author:

Lee Ji-Won,Mizuno Kaito,Watanabe Haruhisa,Lee In-Hee,Tsumita Takuya,Hida Kyoko,Yawaka Yasutaka,Kitagawa Yoshimasa,Hasebe Akira,Iimura Tadahiro,Kong Sek Won

Funder

Japan Society for the Promotion of Science

Takeda Science Foundation

JSBMR Rising Star Grant

National Institute of Health

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s12974-024-03192-7.pdf

Reference95 articles.

1. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the national institute on aging-Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:263–9.

2. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239–59.

3. Hur JY. gamma-Secretase in Alzheimer’s disease. Exp Mol Med. 2022;54:433–46.

4. Bertram L, Tanzi RE. Thirty years of Alzheimer’s disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci. 2008;9:768–78.

5. Coric V, van Dyck CH, Salloway S, Andreasen N, Brody M, Richter RW, Soininen H, Thein S, Shiovitz T, Pilcher G, et al. Safety and tolerability of the gamma-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease. Arch Neurol. 2012;69:1430–40.